Cargando…
Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?
INTRODUCTION: Acute myocardial infarction (AMI) could be considered to be a state of inflammation. Many inflammatory markers have been evaluated in the AMI setting so far. Presepsin (PSP) is a novel biomarker for diagnosis and prognosis of systemic inflammation that has not been studied in the AMI s...
Autores principales: | Caglar, Fatma Nihan Turhan, Isiksacan, Nilgun, Biyik, Ismail, Opan, Selcuk, Cebe, Hulya, Akturk, Ibrahim Faruk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596112/ https://www.ncbi.nlm.nih.gov/pubmed/28905041 http://dx.doi.org/10.5114/amsad.2017.66827 |
Ejemplares similares
-
Serum Presepsin Levels Are Not Elevated in Patients with Controlled Hypertension
por: Biyik, Ismail, et al.
Publicado: (2018) -
Prognostic value of sCD14-ST (presepsin) in cardiac surgery
por: Popov, Dmitry, et al.
Publicado: (2015) -
The role of insulin-like growth factor-1 in development of coronary no-reflow and severity of coronary artery disease in patients with acute myocardial infarction
por: Akturk, Ibrahim Faruk, et al.
Publicado: (2014) -
Development of a newly immunoassay specific for mouse presepsin (sCD14-ST)
por: Takahashi, Gaku, et al.
Publicado: (2022) -
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with cryptogenic stroke in patients with patent foramen ovale
por: Caglar, Fatma Nihan Turhan, et al.
Publicado: (2020)